바이오 소재 시장 규모는 향후 몇 년동안 연평균 14.4%의 성장률을 기록하며 2029년까지 2,625억 6,600만 달러 규모로 성장할 것으로 예상됩니다. 이 기간 동안 성장세는 소비자 선호도 변화, 3D 프린팅 및 적층 가공 분야의 바이오 소재 수요 급증, 생분해성 및 생체 흡수성 바이오 소재 부문의 확대, 개인 맞춤형 의료를 위한 약물 전달 시스템에서의 바이오 소재 채택, 상처 치료 및 조직 재생 분야에서의 바이오 소재 사용 증가 상처 치료 및 조직 재생을 위한 생체재료의 사용 증가 등이 주요 요인으로 작용하고 있습니다. 예측 기간 동안 주요 동향으로는 반응성과 적응성을 갖춘 스마트 바이오소재의 개발, 기능성 향상을 위한 나노기술의 통합, 맞춤형 바이오소재 솔루션으로 이어지는 정밀의료의 중요성, 해양 및 식물 유래 바이오소재 공급원 발굴, 혁신적 혁신적인 용도를 위한 바이오 소재 기업과 의료기관 간의 협업 등이 있습니다.
심혈관 질환의 유병률 증가는 바이오 소재 시장의 성장을 가속하고 있습니다. 심혈관 질환은 고혈압, 흡연, 고콜레스테롤, 운동 부족 등의 요인으로 인해 발생합니다. 심혈관 질환 환자 증가는 당뇨병, 만성 호흡기 질환, 관상동맥질환(CAD), 고혈압과 관련된 심장마비 등 비감염성 질환 증가에 기인합니다. 심장판막, 심폐우회시스템, 스텐트, 인공혈관, 인공심장, 심박조율기 등의 생체재료는 손상되거나 병든 심장조직을 치유하는 메커니즘으로 작용합니다. 예를 들어, 미국 정부기관인 질병통제예방센터(CDC)의 2024년 5월 자료에 따르면, 2022년 미국에서 심장질환으로 인한 사망자는 70만 2,880명이며, 그 중 37만 1,506명이 관상동맥질환으로 인한 사망자입니다. 이에 따라 심혈관 질환 발병률 증가는 바이오 소재 시장 수요를 증가시킬 것으로 예상됩니다.
헬스케어 지출 증가는 바이오소재 시장의 성장을 가속할 것입니다. 헬스케어 지출은 일정 기간 동안 의료 서비스, 치료, 의료 인프라에 할당되는 총 재정적 자원을 의미하며, 일반적으로 국가 또는 기관 수준에서 이루어집니다. 헬스케어 지출은 바이오소재의 경우 연구개발, 제품 개발, 조달, 채용, 규제 준수에 사용됩니다. 예를 들어, 2022년 9월, 벨기에에 본사를 둔 유럽 의료 기술 산업을 대표하는 산업 단체인 MedTech Europe에 따르면, 유럽에서는 평균적으로 국내총생산(GDP)의 약 11%가 헬스케어에 할당되어 있습니다. 이 중 약 7.6%가 의료기술에 쓰이고 있습니다. 유럽 각국의 의료기술에 대한 지출은 헬스케어 총 지출의 약 5%에서 12% 사이입니다. 유럽의 의료기술에 대한 1인당 지출은 약 346.08달러(284유로)에 달할 전망입니다. 따라서 헬스케어 지출 증가는 바이오소재 시장의 성장에 기여할 것으로 보입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나재난, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 바이오소재 시장 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 이용 산업 분석
- 세계의 바이오소재 시장 성장률 분석
- 세계의 바이오소재 시장 실적 : 규모와 성장, 2019-2024년
- 세계의 바이오소재 시장 예측 : 규모와 성장, 2024-2029년, 2034년
- 세계의 바이오소재 유효 시장(TAM)
제6장 시장 세분화
- 세계의 바이오소재 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 금속 바이오소재
- 폴리머 바이오소재
- 천연 바이오소재
- 세라믹
- 세계의 바이오소재 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 심장혈관
- 정형외과
- 안과
- 치과
- 성형외과
- 창상 치유
- 조직공학
- 신경계/중추신경계
- 세계의 바이오소재 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 병원 및 클리닉
- 외래수술센터(ASC)
- 기타 최종사용자
- 세계의 바이오소재 시장 : 금속 바이오소재 서브 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 스테인리스 스틸
- 티타늄 합금
- 코발트 크롬 합금
- 마그네슘 합금
- 세계의 바이오소재 시장 : 폴리머 바이오소재 서브 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 합성 폴리머
- 천연 폴리머
- 생분해성 폴리머
- 세계의 바이오소재 시장 : 천연 바이오소재 서브 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 동물 유래 원료
- 식물 유래 원료
- 세계의 바이오소재 시장 : 세라믹 서브 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 바이오 세라믹
- 다공질 세라믹
- 비다공질 세라믹
제7장 지역별/국가별 분석
- 세계의 바이오소재 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 세계의 바이오소재 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 바이오소재 시장 : 경쟁 구도
- 바이오소재 시장 : 기업 개요
- Corbion N V
- Evonik Industries AG
- Heraeus Medical Components LLC
- Berkeley Advanced Biomaterials Inc.
- Zimmer Biomet Holdings Inc.
제31장 기타 주요 기업 및 혁신 기업
- DSM Biomedical BV
- PolyNovo Limited
- Baxter International Inc.
- Stryker Corporation
- Collagen Solutions plc
- Invibio Ltd.
- Aap Implantate AG
- Cam Bioceramics BV
- CeramTec GmbH
- CoorsTek Medical LLC
- CryoLife Inc.
- Cerapedics Inc.
- Surmodics Inc.
- Secant Group LLC
- GELITA AG
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 시장의 최근 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 바이오소재 시장(2029년) - 가장 새로운 기회를 제공하는 국가
- 바이오소재 시장(2029년) - 가장 새로운 기회를 제공하는 부문
- 바이오소재 시장(2029년) - 성장 전략
제36장 부록
LSH
The biomaterials refer to manmade substances that can be utilized to support tissues or structures in the body. These are natural or synthetic materials that are used in medical applications to support, enhance, or replace damaged tissue or a biological function.
The main types of biomaterials are metallic biomaterial, polymeric biomaterials, natural biomaterials and ceramics. The metallic biomaterials are stainless steels, titanium alloys, and cobalt alloys used to provide internal support to biological tissues. The metallic biomaterials are manmade systems that are utilized in joint replacements, dental implants, orthopedic fixations, and stents to offer internal support to biological tissues. Biomaterials have a wide application in cardiovascular, orthopedic, ophthalmology, dental, plastic surgery, wound healing, tissue engineering and neurological/central nervous system and are used in hospitals and clinics, ambulatory surgical centers and other end users.
The biomaterials market research report is one of a series of new reports from The Business Research Company that provides biomaterials market statistics, including biomaterials industry global market size, regional shares, competitors with a biomaterials market share, detailed biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the biomaterials industry. This biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biomaterials market size has grown rapidly in recent years. It will grow from $134.31 billion in 2024 to $153.55 billion in 2025 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to growing aging population, adoption of biomaterials in orthopedic and dental applications, increasing awareness of environmental sustainability, increased prevalence of chronic conditions medicine, increased demand for medical implants.
The biomaterials market size is expected to see rapid growth in the next few years. It will grow to $262.56 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to shifting consumer preferences, surge in demand for biomaterials in 3d printing and additive manufacturing, expansion of the biodegradable and bioresorbable biomaterials segment, adoption of biomaterials in drug delivery systems for personalized medicine, increasing use of biomaterials in wound care and tissue regeneration. Major trends in the forecast period include development of smart biomaterials with responsive and adaptive properties, integration of nanotechnology for enhanced functionality, emphasis on precision medicine leading to customized biomaterial solutions, exploration of marine and plant-derived biomaterial sources, collaboration between biomaterial companies and healthcare institutions for innovative applications.
The growing prevalence of cardiovascular diseases is propelling the expansion of the biomaterials market. Cardiovascular disorders stem from factors such as high blood pressure, smoking, high cholesterol, and inactivity. The rise in cardiovascular disorder cases is largely attributed to noncommunicable diseases like diabetes, chronic respiratory illnesses, coronary artery disease (CAD), and heart attacks related to hypertension. Biomaterials, including heart valves, cardiopulmonary bypass systems, stents, vascular grafts, complete artificial hearts, and pacemakers, serve as healing mechanisms for damaged and diseased heart tissue. For instance, data from the Centers for Disease Control and Prevention (CDC), a US government agency, indicated in May 2024 that there were 702,880 deaths from heart disease in the United States in 2022, with 371,506 of those attributable to coronary artery disease. Consequently, the rising incidence of cardiovascular diseases is expected to boost the demand for the biomaterials market.
The increasing healthcare spending will propel the growth of the biomaterials market. Healthcare spending refers to the total financial resources allocated for medical services, treatments, and healthcare infrastructure within a given period, typically on a national or institutional level. Healthcare spending is used in biomaterials for research and development, product development, procurement and adoption, and regulatory compliance. For instance, in September 2022, according to MedTech Europe, a Belgium-based European trade association representing the medical technology industries, in Europe, on average, approximately 11% of gross domestic product (GDP) is allocated to healthcare. Out of this, about 7. 6% is attributed to medical technologies. The spending on medical technology across European countries ranges from around 5% to 12% of the total healthcare expenditure. The per capita expenditure on medical technology in Europe stands at approximately $346. 08 (€284). Therefore, increasing healthcare spending will contribute to the growth of the biomaterials market.
Strategic partnerships are emerging as a significant trend in the biomaterials market. Leading companies are increasingly focusing on collaborations to develop new implants and combination devices based on biomaterials, leveraging each other's expertise, technology, and resources. These partnerships also aim to boost the adoption of biomaterials. By joining forces, companies can gain a competitive advantage in the market and enhance revenue. For example, in June 2023, IFF, a US-based corporation, launched the Designed Enzymatic Biomaterials (DEB) technology platform to meet the rising demand for sustainable, high-performance materials. This platform enables precise drug delivery through engineered enzymes that release therapeutic agents in response to specific biological cues. It is also vital in tissue engineering, where enzymatic reactions promote tissue regeneration by facilitating cell growth and allowing controlled degradation of scaffolds at predetermined rates. The DEB technology enables the customization of biobased polysaccharides that can match or surpass the performance of traditional petroleum-based polymers, thereby facilitating greater market adoption.
Major companies operating in the biomaterials market focus on technological advancements, such as the designed enzymatic biomaterials (DEB) technology platform, to deliver sustainable biopolymers and gain a competitive advantage. The enzymatic biomaterials (DEB) technology platform involves the use of enzymes to design and modify materials for various applications, including drug delivery, tissue engineering, and diagnostics. For instance, in June 2023, International Flavors & Fragrances Inc., a US-based producer of flavors, fragrances, and cosmetic actives, launched the enzymatic biomaterials technology platform for the development of biobased materials at scale. Designed to deliver meaningful sustainability benefits with performance comparable to or superior to fossil-based materials, DEB technology helps to address growing preferences for environmentally friendly, high-performance biopolymers. The technology platform allows producers to fulfill regulatory changes and increasing consumer demand by replacing traditional fossil-based synthetic polymers.
In October 2024, RTI Surgical (RTI), a US-based medical equipment manufacturing company, acquired Collagen Solutions plc for an undisclosed amount. The objective of RTI Surgical's acquisition of Collagen Solutions is to broaden its soft tissue portfolio and improve its capabilities in the regenerative medicine sector. Collagen Solutions plc is a US-based supplier, developer, and manufacturer of medical-grade collagen, tissues, and other biomaterials for use in regenerative medicine, medical devices, and research.
Major companies operating in the biomaterials market include Corbion N V, Evonik Industries AG, Heraeus Medical Components LLC, Berkeley Advanced Biomaterials Inc., Zimmer Biomet Holdings Inc., DSM Biomedical BV, PolyNovo Limited, Baxter International Inc., Stryker Corporation, Collagen Solutions plc, Invibio Ltd., Aap Implantate AG, Cam Bioceramics BV, CeramTec GmbH, CoorsTek Medical LLC, CryoLife Inc., Cerapedics Inc., Surmodics Inc., Secant Group LLC, GELITA AG, Quattroflow GmbH, Kyocera Corporation, Wright Medical Group NV, KLS Martin Group GmbH & Co KG, Meccellis Biotechnology Co Ltd., Bio-on SpA, Coloplast A/S, Collagen Matrix Inc., IntrinsiQ Materials Inc., PolyActiva Pty Ltd
North America was the largest region in the biomaterials market in 2024. The regions covered in the biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.
The biomaterials market consists of sales of metals, polymers, and composites. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biomaterials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biomaterials market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Metallic Biomaterial; Polymeric Biomaterials; Natural Biomaterials; Ceramics
- 2) By Application: Cardiovascular; Orthopedic; Ophthalmology; Dental; Plastic Surgery; Wound Healing; Tissue Engineering; Neurological/Central Nervous System
- 3) By End Use: Hospitals And Clinics; Ambulatory Surgical Centers; Other End Users
- Subsegments:
- 1) By Metallic Biomaterials: Stainless Steel; Titanium Alloys; Cobalt-Chromium Alloys; Magnesium Alloys
- 2) By Polymeric Biomaterials: Synthetic Polymers; Natural Polymers; Biodegradable Polymers
- 3) By Natural Biomaterials: Animal-Derived Materials; Plant-Derived Materials
- 4) By Ceramics: Bioceramics; Porous Ceramics; Non-porous Ceramics
- Companies Mentioned: Corbion N V; Evonik Industries AG; Heraeus Medical Components LLC; Berkeley Advanced Biomaterials Inc.; Zimmer Biomet Holdings Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Biomaterials Market Characteristics
3. Biomaterials Market Trends And Strategies
4. Biomaterials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Biomaterials Growth Analysis And Strategic Analysis Framework
- 5.1. Global Biomaterials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Biomaterials Market Growth Rate Analysis
- 5.4. Global Biomaterials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Biomaterials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Biomaterials Total Addressable Market (TAM)
6. Biomaterials Market Segmentation
- 6.1. Global Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Metallic Biomaterial
- Polymeric Biomaterials
- Natural Biomaterials
- Ceramics
- 6.2. Global Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cardiovascular
- Orthopedic
- Ophthalmology
- Dental
- Plastic Surgery
- Wound Healing
- Tissue Engineering
- Neurological/Central Nervous System
- 6.3. Global Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Other End Users
- 6.4. Global Biomaterials Market, Sub-Segmentation Of Metallic Biomaterials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Stainless Steel
- Titanium Alloys
- Cobalt-Chromium Alloys
- Magnesium Alloys
- 6.5. Global Biomaterials Market, Sub-Segmentation Of Polymeric Biomaterials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Synthetic Polymers
- Natural Polymers
- Biodegradable Polymers
- 6.6. Global Biomaterials Market, Sub-Segmentation Of Natural Biomaterials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Animal-Derived Materials
- Plant-Derived Materials
- 6.7. Global Biomaterials Market, Sub-Segmentation Of Ceramics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bioceramics
- Porous Ceramics
- Non-porous Ceramics
7. Biomaterials Market Regional And Country Analysis
- 7.1. Global Biomaterials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Biomaterials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Biomaterials Market
- 8.1. Asia-Pacific Biomaterials Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Biomaterials Market
- 9.1. China Biomaterials Market Overview
- 9.2. China Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Biomaterials Market
- 10.1. India Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Biomaterials Market
- 11.1. Japan Biomaterials Market Overview
- 11.2. Japan Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Biomaterials Market
- 12.1. Australia Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Biomaterials Market
- 13.1. Indonesia Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Biomaterials Market
- 14.1. South Korea Biomaterials Market Overview
- 14.2. South Korea Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Biomaterials Market
- 15.1. Western Europe Biomaterials Market Overview
- 15.2. Western Europe Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Biomaterials Market
- 16.1. UK Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Biomaterials Market
- 17.1. Germany Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Biomaterials Market
- 18.1. France Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Biomaterials Market
- 19.1. Italy Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Biomaterials Market
- 20.1. Spain Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Biomaterials Market
- 21.1. Eastern Europe Biomaterials Market Overview
- 21.2. Eastern Europe Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Biomaterials Market
- 22.1. Russia Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Biomaterials Market
- 23.1. North America Biomaterials Market Overview
- 23.2. North America Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Biomaterials Market
- 24.1. USA Biomaterials Market Overview
- 24.2. USA Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Biomaterials Market
- 25.1. Canada Biomaterials Market Overview
- 25.2. Canada Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Biomaterials Market
- 26.1. South America Biomaterials Market Overview
- 26.2. South America Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Biomaterials Market
- 27.1. Brazil Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Biomaterials Market
- 28.1. Middle East Biomaterials Market Overview
- 28.2. Middle East Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Biomaterials Market
- 29.1. Africa Biomaterials Market Overview
- 29.2. Africa Biomaterials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Biomaterials Market Competitive Landscape And Company Profiles
- 30.1. Biomaterials Market Competitive Landscape
- 30.2. Biomaterials Market Company Profiles
- 30.2.1. Corbion N V Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Heraeus Medical Components LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Berkeley Advanced Biomaterials Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Biomaterials Market Other Major And Innovative Companies
- 31.1. DSM Biomedical BV
- 31.2. PolyNovo Limited
- 31.3. Baxter International Inc.
- 31.4. Stryker Corporation
- 31.5. Collagen Solutions plc
- 31.6. Invibio Ltd.
- 31.7. Aap Implantate AG
- 31.8. Cam Bioceramics BV
- 31.9. CeramTec GmbH
- 31.10. CoorsTek Medical LLC
- 31.11. CryoLife Inc.
- 31.12. Cerapedics Inc.
- 31.13. Surmodics Inc.
- 31.14. Secant Group LLC
- 31.15. GELITA AG
32. Global Biomaterials Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Biomaterials Market
34. Recent Developments In The Biomaterials Market
35. Biomaterials Market High Potential Countries, Segments and Strategies
- 35.1 Biomaterials Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Biomaterials Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Biomaterials Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
